Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
biotech
clinical trials
eli lilly
life sciences
merck
migraine
2
×
national
national blog main
national top stories
new york blog main
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
allergan
alzheimer's disease
amgen
antibiotics
axial spondyloarthritis
bausch health
biogen
biohaven
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
cgpr
cluster headache
crispr
deals
detroit blog main
detroit top stories
What
new
adults
allergan
approval
approved
bio
biogen’s
biopharmaceutical
class
companies
convo
drug
earlier
failures
fda
littered
medicines
migraine
monday
nash
news
nod
pill
price
remains
road
roundup
strategy
talk
treat
treatment
ubrelvy
ubrogepant
wins
Language
unset
Current search:
migraine
×
abbvie
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More